Search results
Results from the WOW.Com Content Network
YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers. YM ...
In a reverse stock split, your current shares are exchanged for fewer shares. When the split occurs, the share price also changes automatically to reflect the exchange ratio. That is, regardless ...
Image source: Getty Images. Stock-split stock No. 2 to buy hand over fist in 2025: Sony Group. The second stock-split stock that investors would be wise to scoop up in 2025 in Japan-based ...
Incyte (NAS: INCY) and Novartis' (NYS: NVS) ruxolitinib has a clear lead over YM BioSciences' (ASE: YMI) CYT387, but that hasn't stopped investors from making a bet on the YM BioSciences ...
The main effect of stock splits is an increase in the liquidity of a stock: [3] there are more buyers and sellers for 10 shares at $10 than 1 share at $100. Some companies avoid a stock split to obtain the opposite strategy: by refusing to split the stock and keeping the price high, they reduce trading volume.
Giddy from GileadIf you owned shares in YM Biosciences (ASE: YMI) , you're. Santa came early for some investors. Several health-care stocks took a sleigh ride up the charts. Here are three of the ...
Image source: Getty Images. A stock split is a tool publicly traded companies can utilize to adjust their share prices and outstanding share counts by the same factor. A company's market cap and ...
In those cases, companies will sometimes do a reverse stock split, in which they exchange one share of stock at a higher price for several shares at the current, lower price. It is the opposite of ...